Postmarketing commitment safety study of HZ/su to evaluate pregnancy exposures and outcomes in immunodeficient or immunosuppressed women between 18 and 49 years of age (EPI-ZOSTER-039 VS US DB 214420)

31/03/2023
05/09/2025
EU PAS number:
EUPAS104070
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol_Amendment_2_Anonymized

English (1.03 MB - PDF) View document
Updated protocol

Protocol Amendment 3 Anonymised 17 Apr 2025.pdf

First published: 27/05/2025
English (1.27 MB - PDF) View document
Study results
Study report
Other information